1. Home
  2. EVLV vs AVXL Comparison

EVLV vs AVXL Comparison

Compare EVLV & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVLV
  • AVXL
  • Stock Information
  • Founded
  • EVLV 2013
  • AVXL 2004
  • Country
  • EVLV United States
  • AVXL United States
  • Employees
  • EVLV N/A
  • AVXL N/A
  • Industry
  • EVLV Computer peripheral equipment
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EVLV Technology
  • AVXL Health Care
  • Exchange
  • EVLV Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • EVLV 680.0M
  • AVXL 761.3M
  • IPO Year
  • EVLV N/A
  • AVXL N/A
  • Fundamental
  • Price
  • EVLV $4.44
  • AVXL $8.25
  • Analyst Decision
  • EVLV Strong Buy
  • AVXL Strong Buy
  • Analyst Count
  • EVLV 4
  • AVXL 2
  • Target Price
  • EVLV $5.31
  • AVXL $44.00
  • AVG Volume (30 Days)
  • EVLV 2.0M
  • AVXL 657.5K
  • Earning Date
  • EVLV 05-20-2025
  • AVXL 05-13-2025
  • Dividend Yield
  • EVLV N/A
  • AVXL N/A
  • EPS Growth
  • EVLV N/A
  • AVXL N/A
  • EPS
  • EVLV N/A
  • AVXL N/A
  • Revenue
  • EVLV $103,865,000.00
  • AVXL N/A
  • Revenue This Year
  • EVLV $25.08
  • AVXL N/A
  • Revenue Next Year
  • EVLV $27.16
  • AVXL N/A
  • P/E Ratio
  • EVLV N/A
  • AVXL N/A
  • Revenue Growth
  • EVLV 30.54
  • AVXL N/A
  • 52 Week Low
  • EVLV $2.01
  • AVXL $3.51
  • 52 Week High
  • EVLV $4.65
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • EVLV 67.39
  • AVXL 40.05
  • Support Level
  • EVLV $4.00
  • AVXL $8.20
  • Resistance Level
  • EVLV $4.28
  • AVXL $8.81
  • Average True Range (ATR)
  • EVLV 0.30
  • AVXL 0.41
  • MACD
  • EVLV 0.04
  • AVXL -0.12
  • Stochastic Oscillator
  • EVLV 90.65
  • AVXL 3.13

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and advanced sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase and primarily under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: